Name: Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: BT3390
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.3 STUDY SCOPE 36 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 36 1.3.2 INCLUSIONS AND EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.4 CURRENCY CONSIDERED 38 1.5 STAKEHOLDERS 38 1.6 SUMMARY OF CHANGES 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.1.1 SECONDARY DATA 40 2.1.2 PRIMARY DATA 41 2.2 MARKET SIZE ESTIMATION 43 2.2.1 INSIGHTS FROM PRIMARIES 45 2.2.2 TOP-DOWN APPROACH 46 2.3 GROWTH RATE FORECAST 47 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49 2.5 RESEARCH ASSUMPTIONS 50 2.6 RESEARCH LIMITATIONS 50 2.7 RISK ASSESSMENT 51 3 EXECUTIVE SUMMARY 52 4 PREMIUM INSIGHTS 56 4.1 LIVE CELL IMAGING MARKET OVERVIEW 56 4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING AND COUNTRY, 2024 57 4.3 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 58 4.4 LIVE CELL IMAGING MARKET, BY END USER, 2024 58 4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 61 5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 61 5.2.1.2 Rising incidence of cancer 62 5.2.1.3 Growing availability of research funds 63 5.2.1.4 Advancements in imaging technology 65 5.2.2 RESTRAINTS 66 5.2.2.1 Expensive high-content screening systems 66 5.2.3 OPPORTUNITIES 66 5.2.3.1 Increasing adoption of live cell imaging technologies in emerging markets 66 5.2.3.2 Growing applications of live cell imaging in personalized medicine 67 5.2.4 CHALLENGES 67 5.2.4.1 Maintenance of cell viability and cellular environment in cell cultures 67 5.2.4.2 Image analysis and data management 67 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68 5.4 PRICING ANALYSIS 68 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 69 5.4.2 AVERAGE SELLING PRICE, BY REGION 71 5.5 VALUE CHAIN ANALYSIS 73 5.6 ECOSYSTEM ANALYSIS 74 5.7 INVESTMENT AND FUNDING ACTIVITY 76 5.8 TECHNOLOGY ANALYSIS 77 5.8.1 KEY TECHNOLOGIES 77 5.8.1.1 Fluorescence microscopy 77 5.8.1.2 Confocal microscopy 77 5.8.1.3 Super-resolution microscopy 77 5.8.1.4 Förster resonance energy transfer 78 5.8.1.5 Fluorescence recovery after photobleaching 78 5.8.2 COMPLEMENTARY TECHNOLOGIES 78 5.8.2.1 Image analysis software 78 5.8.2.2 Microfluidics 79 5.8.2.3 Optogenetics 79 5.8.2.4 Multiphoton microscopy 79 5.8.3 ADJACENT TECHNOLOGIES 80 5.8.3.1 Fixed cell imaging 80 5.9 PATENT ANALYSIS 80 5.10 TRADE DATA ANALYSIS 84 5.10.1 IMPORT DATA FOR HS CODE 901120 84 5.10.2 EXPORT DATA FOR HS CODE 901120 85 5.11 KEY CONFERENCES AND EVENTS, 2025–2026 86 5.12 REGULATORY LANDSCAPE 87 5.12.1 REGULATORY FRAMEWORK 87 5.12.1.1 North America 87 5.12.1.1.1 US 87 5.12.1.1.2 Canada 88 5.12.1.2 Europe 88 5.12.1.2.1 UK 88 5.12.1.2.2 European Union 88 5.12.1.3 Asia Pacific 89 5.12.1.3.1 Japan 89 5.12.1.3.2 South Korea 89 5.12.1.3.3 China 89 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 5.13 PORTER’S FIVE FORCES ANALYSIS 91 5.13.1 THREAT FROM NEW ENTRANTS 92 5.13.2 THREAT FROM SUBSTITUTES 93 5.13.3 BARGAINING POWER OF SUPPLIERS 93 5.13.4 BARGAINING POWER OF BUYERS 93 5.13.5 INTENSITY OF COMPETITIVE RIVALRY 93 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 94 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 5.14.2 BUYING CRITERIA 95 5.15 IMPACT OF AI/GENERATIVE AI ON LIVE CELL IMAGING MARKET 96 5.15.1 INTRODUCTION 96 5.15.2 KEY COMPANIES IMPLEMENTING AI 97 5.15.3 AI USE CASES 98 5.15.4 FUTURE OF AI IN LIVE CELL IMAGING ECOSYSTEM 98 5.16 IMPACT OF 2025 US TARIFF ON LIVE CELL IMAGING MARKET 99 5.16.1 INTRODUCTION 99 5.16.2 KEY TARIFF RATES 99 5.16.3 PRICE IMPACT ANALYSIS 101 5.16.4 IMPACT ON COUNTRY/REGION 101 5.16.4.1 US 101 5.16.4.2 Europe 102 5.16.4.3 Asia Pacific 103 5.16.5 IMPACT ON END-USE INDUSTRIES 103 5.16.5.1 Pharmaceutical & biotech companies 104 5.16.5.2 Academic & research institutes 104 5.16.5.3 Contract research organizations 105 6 LIVE CELL IMAGING MARKET, BY OFFERING 106 6.1 INTRODUCTION 107 6.2 PRODUCTS 107 6.2.1 INSTRUMENTS 107 6.2.1.1 Microscopes 112 6.2.1.1.1 Ongoing technological advancements in microscopes to support growth 112 6.2.1.2 Cell imaging systems 116 6.2.1.2.1 Seamless integration and workflow efficiency of standalone systems to boost market 116 6.2.1.3 Cell analyzers 120 6.2.1.3.1 Accuracy and reproducibility of cell analyzers to encourage growth 120 6.2.1.4 Accessories 123 6.2.1.4.1 Increasing demand for live cell imaging in life science research to accelerate growth 123 6.2.2 CONSUMABLES 127 6.2.2.1 Reagents 130 6.2.2.1.1 Widespread usage of reagents in life science research to foster growth 130 6.2.2.2 Assay kits 134 6.2.2.2.1 Higher customer convenience and time-saving solutions to amplify growth 134 6.2.2.3 Media 138 6.2.2.3.1 Increasing investments in cell-based research to intensify growth 138 6.2.2.4 Other consumables 141 6.3 SOFTWARE 145 6.3.1 INCREASING ADVANCEMENTS IN IMAGE ACQUISITION TO SUPPORT GROWTH 145 6.4 SERVICES 149 6.4.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO FUEL MARKET 149 7 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 152 7.1 INTRODUCTION 153 7.2 TIME-LAPSE MICROSCOPY 153 7.2.1 GROWING DEMAND FOR HIGH CONTENT AND HIGH THROUGHPUT ANALYSIS IN PRECLINICAL STUDIES TO DRIVE MARKET 153 7.3 FLUORESCENCE RESONANCE ENERGY TRANSFER 157 7.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST MARKET 157 7.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING 160 7.4.1 INCREASING ADVANCEMENTS IN FLUORESCENT PROTEINS TO SPUR GROWTH 160 7.5 HIGH-CONTENT SCREENING 164 7.5.1 GROWING FOCUS ON DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE MARKET 164 7.6 OTHER TECHNOLOGIES 167 8 LIVE CELL IMAGING MARKET, BY APPLICATION 171 8.1 INTRODUCTION 172 8.2 CELL BIOLOGY RESEARCH 172 8.2.1 INCREASING FOCUS ON DISEASE RESEARCH TO SUPPORT GROWTH 172 8.3 DRUG DISCOVERY 176 8.3.1 GROWING USE OF HIGH-CONTENT SCREENING CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO BOOST MARKET 176 8.4 STEM CELL RESEARCH 179 8.4.1 INCREASING FOCUS ON REGENERATIVE MEDICINE TO EXPEDITE GROWTH 179 8.5 DEVELOPMENTAL BIOLOGY 183 8.5.1 RISING INTEREST IN ORGANOGENESIS AND TISSUE MORPHOGENESIS TO PROMOTE GROWTH 183 9 LIVE CELL IMAGING MARKET, BY END USER 187 9.1 INTRODUCTION 188 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 188 9.2.1 INCREASING R&D ACTIVITIES TO DEVELOP NEW DRUGS TO SUPPORT GROWTH 188 9.3 ACADEMIC & RESEARCH INSTITUTES 192 9.3.1 RISING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO AID GROWTH 192 9.4 CONTRACT RESEARCH ORGANIZATIONS 195 9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET 195 10 LIVE CELL IMAGING MARKET, BY REGION 199 10.1 INTRODUCTION 200 10.2 NORTH AMERICA 200 10.2.1 MACROECONOMIC ANALYSIS FOR NORTH AMERICA 201 10.2.2 US 205 10.2.2.1 Presence of major players and increasing investments in life science research to sustain growth 205 10.2.3 CANADA 208 10.2.3.1 Government initiatives to promote research to aid growth 208 10.3 EUROPE 211 10.3.1 MACROECONOMIC ANALYSIS FOR EUROPE 212 10.3.2 GERMANY 215 10.3.2.1 Presence of large number of academic research institutes to boost market 215 10.3.3 UK 218 10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to foster market 218 10.3.4 FRANCE 220 10.3.4.1 Booming pharmaceutical manufacturing industry to drive market growth 220 10.3.5 ITALY 223 10.3.5.1 Strong research tradition, government funding, and collaborative research networks to fuel growth 223 10.3.6 SPAIN 226 10.3.6.1 Rising R&D expenditure to boost market 226 10.3.7 REST OF EUROPE 228 10.4 ASIA PACIFIC 232 10.4.1 MACROECONOMIC ANALYSIS FOR ASIA PACIFIC 232 10.4.2 CHINA 237 10.4.2.1 Low manufacturing cost and surge in research & development investments to spur growth 237 10.4.3 JAPAN 240 10.4.3.1 Presence of large geriatric population and increasing research activities to bolster growth 240 10.4.4 INDIA 243 10.4.4.1 Growing pharmaceutical industry to propel market 243 10.4.5 SOUTH KOREA 246 10.4.5.1 Ongoing collaborations and research initiatives among market players to encourage growth 246 10.4.6 AUSTRALIA 249 10.4.6.1 Robust healthcare infrastructure to facilitate growth 249 10.4.7 REST OF ASIA PACIFIC 252 10.5 LATIN AMERICA 256 10.5.1 MACROECONOMIC ANALYSIS FOR LATIN AMERICA 256 10.5.2 BRAZIL 260 10.5.2.1 Growing focus on biotechnology and biomedical innovations to drive market 260 10.5.3 MEXICO 262 10.5.3.1 Low manufacturing cost and large population to support growth 262 10.5.4 REST OF LATIN AMERICA 265 10.6 MIDDLE EAST 268 10.6.1 MACROECONOMIC ANALYSIS FOR MIDDLE EAST 268 10.6.2 GCC COUNTRIES 272 10.6.2.1 Saudi Arabia 275 10.6.2.1.1 Increasing life science research funding to aid growth 275 10.6.2.2 UAE 278 10.6.2.2.1 Presence of research institutes supporting live cell imaging studies to foster growth 278 10.6.2.3 Rest of GCC Countries 280 10.6.3 REST OF MIDDLE EAST 283 10.7 AFRICA 286 10.7.1 GOVERNMENT INITIATIVES TO CONTRIBUTE TO GROWTH 286 10.7.2 MACROECONOMIC ANALYSIS FOR AFRICA 286 11 COMPETITIVE LANDSCAPE 290 11.1 INTRODUCTION 290 11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 290 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET 291 11.3 REVENUE ANALYSIS, 2022–2024 293 11.4 MARKET SHARE ANALYSIS, 2024 294 11.5 COMPANY VALUATION AND FINANCIAL METRICS 297 11.6 BRAND/PRODUCT COMPARISON 298 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 299 11.7.1 STARS 299 11.7.2 EMERGING LEADERS 299 11.7.3 PERVASIVE PLAYERS 299 11.7.4 PARTICIPANTS 300 11.8 COMPANY FOOTPRINT, KEY PLAYERS, 2024 301 11.8.1 COMPANY FOOTPRINT 301 11.8.2 REGION FOOTPRINT 302 11.8.3 OFFERING FOOTPRINT 303 11.8.4 APPLICATION FOOTPRINT 305 11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 306 11.9.1 PROGRESSIVE COMPANIES 306 11.9.2 RESPONSIVE COMPANIES 306 11.9.3 DYNAMIC COMPANIES 306 11.9.4 STARTING BLOCKS 306 11.10 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 308 11.10.1 DETAILED LIST OF KEY STARTUPS/SMES 308 11.10.2 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309 11.11 COMPETITIVE SCENARIO 310 11.11.1 PRODUCT LAUNCHES AND UPGRADES 310 11.11.2 DEALS 311 11.11.3 EXPANSIONS 312 12 COMPANY PROFILE 313 12.1 KEY PLAYERS 313 12.1.1 DANAHER 313 12.1.1.1 Business overview 313 12.1.1.2 Products offered 314 12.1.1.3 Recent developments 316 12.1.1.3.1 Product launches and upgrades 316 12.1.1.3.2 Deals 316 12.1.1.4 MnM view 317 12.1.1.4.1 Key strengths 317 12.1.1.4.2 Strategic choices 317 12.1.1.4.3 Weaknesses and competitive threats 317 12.1.2 ZEISS GROUP 318 12.1.2.1 Business overview 318 12.1.2.2 Products offered 319 12.1.2.3 Recent developments 320 12.1.2.3.1 Product launches and upgrades 320 12.1.2.3.2 Deals 321 12.1.2.3.3 Expansions 321 12.1.2.4 MnM view 321 12.1.2.4.1 Key strengths 321 12.1.2.4.2 Strategic choices 322 12.1.2.4.3 Weaknesses and competitive threats 322 12.1.3 THERMO FISHER SCIENTIFIC INC. 323 12.1.3.1 Business overview 323 12.1.3.2 Products offered 324 12.1.3.3 Recent developments 325 12.1.3.3.1 Deals 325 12.1.3.4 MnM view 326 12.1.3.4.1 Key strengths 326 12.1.3.4.2 Strategic choices 326 12.1.3.4.3 Weaknesses and competitive threats 326 12.1.4 REVVITY 327 12.1.4.1 Business overview 327 12.1.4.2 Products offered 328 12.1.4.3 Recent developments 329 12.1.4.3.1 Product launches and upgrades 329 12.1.4.4 MnM view 330 12.1.4.4.1 Key strengths 330 12.1.4.4.2 Strategic choices 330 12.1.4.4.3 Weaknesses and competitive threats 330 12.1.5 SARTORIUS AG 331 12.1.5.1 Business overview 331 12.1.5.2 Products offered 332 12.1.5.3 Recent developments 333 12.1.5.3.1 Deals 333 12.1.5.4 MnM view 333 12.1.5.4.1 Key strength 333 12.1.5.4.2 Strategic choices 333 12.1.5.4.3 Weaknesses and competitive threats 333 12.1.6 NIKON CORPORATION 334 12.1.6.1 Business overview 334 12.1.6.2 Products offered 335 12.1.6.3 Recent developments 336 12.1.6.3.1 Expansions 336 12.1.7 EVIDENT 337 12.1.7.1 Business overview 337 12.1.7.2 Products offered 337 12.1.7.3 Recent developments 338 12.1.7.3.1 Product launches and upgrades 338 12.1.8 AGILENT TECHNOLOGIES, INC. 339 12.1.8.1 Business overview 339 12.1.8.2 Products offered 340 12.1.8.3 Recent developments 342 12.1.8.3.1 Product launches and upgrades 342 12.1.9 NANOENTEK 343 12.1.9.1 Business overview 343 12.1.9.2 Products offered 343 12.1.10 BRUKER 344 12.1.10.1 Business overview 344 12.1.10.2 Products offered 345 12.1.10.3 Recent developments 346 12.1.10.3.1 Deals 346 12.1.11 BD 347 12.1.11.1 Business overview 347 12.1.11.2 Products offered 348 12.1.12 MERCK KGAA 349 12.1.12.1 Business overview 349 12.1.12.2 Products offered 351 12.1.13 BIO-RAD LABORATORIES, INC. 352 12.1.13.1 Business overview 352 12.1.13.2 Products offered 353 12.1.14 TECAN TRADING AG 354 12.1.14.1 Business overview 354 12.1.15 SYSMEX CORPORATION 356 12.1.15.1 Business overview 356 12.1.15.2 Products offered 357 12.1.16 CORNING INCORPORATED 358 12.1.16.1 Business overview 358 12.1.16.2 Products offered 359 12.2 OTHER PLAYERS 360 12.2.1 AXION BIOSYSTEMS, INC. 360 12.2.2 BLUE-RAY BIOTECH CORP. 361 12.2.3 CURIOSIS INC. 361 12.2.4 CYTENA GMBH 362 12.2.5 ABBERIOR GMBH 363 12.2.6 PHASE HOLOGRAPHIC IMAGING PHI AB 364 12.2.7 ALIGNED GENETICS INC. 365 12.2.8 CHERRY BIOTECH 365 12.2.9 NANOLIVE SA 366 12.2.10 CYTOTRONICS 367 12.2.11 ETALUMA, INC. 368 12.2.12 TISSUEGNOSTICS GMBH 369 13 APPENDIX 370 13.1 DISCUSSION GUIDE 370 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 373 13.3 CUSTOMIZATION OPTIONS 375 13.4 RELATED REPORTS 375 13.5 AUTHOR DETAILS 376

_ TABLE 1 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 61 TABLE 2 ESTIMATED NEW CANCER CASES IN US, 2025 62 TABLE 3 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS, BY KEY PLAYER, 2022–2024 69 TABLE 4 AVERAGE SELLING PRICE, BY REGION, 2024 72 TABLE 5 LIVE CELL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 75 TABLE 6 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2025 80 TABLE 7 LIVE CELL IMAGING MARKET: PATENT ANALYSIS, 2024 82 TABLE 8 IMPORT DATA FOR LIVE CELL IMAGING PRODUCTS (HS CODE 901120), BY COUNTRY, 2020–2024 (USD THOUSAND) 84 TABLE 9 EXPORT DATA FOR HS CODE 901120, BY COUNTRY, 2020–2024 (USD THOUSAND) 85 TABLE 10 LIVE CELL IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 86 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 15 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 92 TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 94 TABLE 17 BUYING CRITERIA, BY END USER 95 TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 99 TABLE 19 LIVE CELL IMAGING PRODUCT-RELATED TARIFF REVISION 100 TABLE 20 IMPACT OF US TARIFF ON END-USE APPLICATIONS OF LIVE CELL IMAGING PRODUCTS 103 TABLE 21 LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 107 TABLE 22 INSTRUMENTS OFFERED BY KEY MARKET PLAYERS 108 TABLE 23 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 24 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 25 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 26 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 27 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 28 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 29 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 30 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 31 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 32 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 33 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 34 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 35 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 36 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 37 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 38 CELL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 116 TABLE 39 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 40 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 41 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 42 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 43 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 44 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 45 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 46 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 120 TABLE 47 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 48 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 49 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 50 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 51 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 52 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 53 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 54 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 123 TABLE 55 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 56 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 57 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 58 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 59 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 60 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 61 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 62 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 63 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 64 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 65 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 66 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 67 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 68 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 69 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 70 REAGENTS OFFERED BY KEY MARKET PLAYERS 131 TABLE 71 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 72 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 73 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 74 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 75 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 76 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 77 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 78 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 134 TABLE 79 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 80 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 81 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 82 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLE MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 83 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 84 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 85 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 86 MEDIA OFFERED BY KEY MARKET PLAYERS 138 TABLE 87 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 88 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 89 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 90 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 91 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 92 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 93 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLE MARKET FOR MEDIA, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 94 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 142 TABLE 95 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 96 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 97 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 98 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 99 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 100 MIDDLE EAST: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 101 GCC COUNTRIES: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 102 SOFTWARE OFFERED BY KEY MARKET PLAYERS 145 TABLE 103 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 104 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 105 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 107 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 108 MIDDLE EAST: LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 109 GCC COUNTRIES: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 110 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 111 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 112 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 113 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 114 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 115 MIDDLE EAST: LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 116 GCC COUNTRIES: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 117 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 153 TABLE 118 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 119 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 120 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 121 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 122 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 123 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 124 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 125 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 126 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 127 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 128 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 129 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 130 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 131 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 132 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 133 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 134 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 135 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 137 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 138 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 139 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 140 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 141 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 142 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 143 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 144 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 145 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 146 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 147 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 148 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 149 ASIA PACIFIC: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 150 LATIN AMERICA: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 151 MIDDLE EAST: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 152 GCC COUNTRIES: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 153 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 154 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 156 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 157 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 158 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 159 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 160 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 161 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 162 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 163 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 164 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 165 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 166 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 167 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 168 LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 169 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 170 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 171 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 172 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 173 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 174 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 175 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 176 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 177 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 178 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 179 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 180 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 181 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 182 LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 188 TABLE 183 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 184 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 185 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 186 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 187 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 188 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 189 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 190 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 191 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 192 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 193 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 194 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 195 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 194 TABLE 196 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 197 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 198 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 199 EUROPE: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 200 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 201 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 202 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 203 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 204 LIVE CELL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 200 TABLE 205 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 202 TABLE 206 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 203 TABLE 207 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 208 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 209 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 204 TABLE 210 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 204 TABLE 211 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 212 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 213 US: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206 TABLE 214 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 215 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 216 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 207 TABLE 217 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 208 TABLE 218 US: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 219 CANADA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 209 TABLE 220 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 221 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 222 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 210 TABLE 223 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 211 TABLE 224 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 211 TABLE 225 EUROPE: KEY MACROECONOMIC INDICATORS 212 TABLE 226 EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 213 TABLE 227 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 228 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 229 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 214 TABLE 230 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 214 TABLE 231 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 214 TABLE 232 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 233 GERMANY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 216 TABLE 234 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 235 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 236 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 217 TABLE 237 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 217 TABLE 238 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 239 UK: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 218 TABLE 240 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 241 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 242 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 219 TABLE 243 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 220 TABLE 244 UK: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 245 FRANCE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 221 TABLE 246 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 247 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 248 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 222 TABLE 249 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 223 TABLE 250 FRANCE: LIVE CEL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 251 ITALY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 224 TABLE 252 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 253 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 254 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225 TABLE 255 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 225 TABLE 256 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 225 TABLE 257 SPAIN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 226 TABLE 258 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 259 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 260 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 227 TABLE 261 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 228 TABLE 262 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 228 TABLE 263 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 229 TABLE 264 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 265 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 266 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 230 TABLE 267 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 231 TABLE 268 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 231 TABLE 269 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 233 TABLE 270 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 235 TABLE 271 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 272 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 273 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 236 TABLE 274 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 236 TABLE 275 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 237 TABLE 276 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 277 CHINA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 238 TABLE 278 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 279 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 280 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239 TABLE 281 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 240 TABLE 282 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 240 TABLE 283 JAPAN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 241 TABLE 284 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 285 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 286 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 242 TABLE 287 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 243 TABLE 288 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 289 INDIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 244 TABLE 290 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 291 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 292 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 293 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 246 TABLE 294 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 295 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 247 TABLE 296 SOUTH KOREA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 297 SOUTH KOREA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 298 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 248 TABLE 299 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 249 TABLE 300 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 301 AUSTRALIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 250 TABLE 302 AUSTRALIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 303 AUSTRALIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 304 AUSTRALIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251 TABLE 305 AUSTRALIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 252 TABLE 306 AUSTRALIA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 307 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 253 TABLE 308 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 309 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 310 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 254 TABLE 311 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 255 TABLE 312 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 313 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 257 TABLE 314 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 257 TABLE 315 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 316 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 317 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 258 TABLE 318 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 259 TABLE 319 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 320 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 321 BRAZIL: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 260 TABLE 322 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 323 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 324 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 325 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 262 TABLE 326 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 327 MEXICO: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 263 TABLE 328 MEXICO: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 329 MEXICO: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 330 MEXICO: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 264 TABLE 331 MEXICO: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 264 TABLE 332 MEXICO: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 333 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 265 TABLE 334 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 335 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 336 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 266 TABLE 337 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 267 TABLE 338 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 267 TABLE 339 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 269 TABLE 340 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 269 TABLE 341 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 342 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 343 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270 TABLE 344 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 271 TABLE 345 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 271 TABLE 346 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 271 TABLE 347 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 272 TABLE 348 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 349 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 350 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 273 TABLE 351 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 274 TABLE 352 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 274 TABLE 353 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 354 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 275 TABLE 355 SAUDI ARABIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 356 SAUDI ARABIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 357 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 277 TABLE 358 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 277 TABLE 359 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 360 UAE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 278 TABLE 361 UAE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 362 UAE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 363 UAE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 279 TABLE 364 UAE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 280 TABLE 365 UAE: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 280 TABLE 366 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 281 TABLE 367 REST OF GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 368 REST OF GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 369 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 282 TABLE 370 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 282 TABLE 371 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 372 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 283 TABLE 373 REST OF MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 374 REST OF MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 375 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 285 TABLE 376 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 285 TABLE 377 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 286 TABLE 378 AFRICA: KEY MACROECONOMIC INDICATORS 287 TABLE 379 AFRICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023–2030 (USD MILLION) 287 TABLE 380 AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 381 AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 382 AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 288 TABLE 383 AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 289 TABLE 384 AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 385 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET, 2022–2025 291 TABLE 386 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION 295 TABLE 387 LIVE CELL IMAGING MARKET: REGION FOOTPRINT 302 TABLE 388 LIVE CELL IMAGING MARKET: OFFERING FOOTPRINT 303 TABLE 389 LIVE CELL IMAGING MARKET: APPLICATION FOOTPRINT 305 TABLE 390 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 308 TABLE 391 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309 TABLE 392 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 310 TABLE 393 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2022–APRIL 2025 311 TABLE 394 LIVE CELL IMAGING MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 312 TABLE 395 DANAHER: COMPANY OVERVIEW 313 TABLE 396 DANAHER: PRODUCTS OFFERED 314 TABLE 397 DANAHER: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 316 TABLE 398 DANAHER: DEALS, JANUARY 2022–APRIL 2025 316 TABLE 399 ZEISS GROUP: COMPANY OVERVIEW 318 TABLE 400 ZEISS GROUP: PRODUCTS OFFERED 319 TABLE 401 ZEISS GROUP: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 320 TABLE 402 ZEISS GROUP: DEALS, JANUARY 2022–APRIL 2025 321 TABLE 403 ZEISS GROUP: EXPANSIONS, JANUARY 2022–APRIL 2025 321 TABLE 404 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 323 TABLE 405 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 324 TABLE 406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–APRIL 2025 325 TABLE 407 REVVITY: COMPANY OVERVIEW 327 TABLE 408 REVVITY: PRODUCTS OFFERED 328 TABLE 409 REVVITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 329 TABLE 410 SARTORIUS AG: COMPANY OVERVIEW 331 TABLE 411 SARTORIUS AG: PRODUCTS OFFERED 332 TABLE 412 SARTORIUS AG: DEALS, JANUARY 2022–APRIL 2025 333 TABLE 413 NIKON CORPORATION: COMPANY OVERVIEW 334 TABLE 414 NIKON CORPORATION: PRODUCTS OFFERED 335 TABLE 415 NIKON CORPORATION: EXPANSIONS, JANUARY 2022–APRIL 2025 336 TABLE 416 EVIDENT: COMPANY OVERVIEW 337 TABLE 417 EVIDENT: PRODUCTS OFFERED 337 TABLE 418 EVIDENT: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022– APRIL 2025 338 TABLE 419 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 339 TABLE 420 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 340 TABLE 421 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–APRIL 2025 342 TABLE 422 NANOENTEK: COMPANY OVERVIEW 343 TABLE 423 NANOENTEK INC.: PRODUCTS OFFERED 343 TABLE 424 BRUKER: COMPANY OVERVIEW 344 TABLE 425 BRUKER: PRODUCTS OFFERED 345 TABLE 426 BRUKER: DEALS, JANUARY 2022–APRIL 2025 346 TABLE 427 BD: COMPANY OVERVIEW 347 TABLE 428 BD: PRODUCTS OFFERED 348 TABLE 429 MERCK KGAA: COMPANY OVERVIEW 349 TABLE 430 MERCK KGAA: PRODUCTS OFFERED 351 TABLE 431 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 352 TABLE 432 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 353 TABLE 433 TECAN TRADING AG: COMPANY OVERVIEW 354 TABLE 434 TECAN TRADING AG: PRODUCTS OFFERED 355 TABLE 435 SYSMEX CORPORATION: COMPANY OVERVIEW 356 TABLE 436 SYSMEX CORPORATION: PRODUCTS OFFERED 357 TABLE 437 CORNING INCORPORATED: COMPANY OVERVIEW 358 TABLE 438 CORNING INCORPORATED: PRODUCTS OFFERED 359 TABLE 439 AXION BIOSYSTEMS, INC.: COMPANY OVERVIEW 360 TABLE 440 BLUE-RAY BIOTECH CORP.: COMPANY OVERVIEW 361 TABLE 441 CURIOSIS INC.: COMPANY OVERVIEW 361 TABLE 442 CYTENA GMBH: COMPANY OVERVIEW 362 TABLE 443 ABBERIOR GMBH: COMPANY OVERVIEW 363 TABLE 444 PHASE HOLOGRAPHIC IMAGING PHI AB: COMPANY OVERVIEW 364 TABLE 445 ALIGNED GENETICS INC.: COMPANY OVERVIEW 365 TABLE 446 CHERRY BIOTECH: COMPANY OVERVIEW 365 TABLE 447 NANOLIVE SA: COMPANY OVERVIEW 366 TABLE 448 CYTOTRONICS: COMPANY OVERVIEW 367 TABLE 449 ETALUMA, INC.: COMPANY OVERVIEW 368 TABLE 450 TISSUEGNOSTICS GMBH: COMPANY OVERVIEW 369 _ FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 36 FIGURE 2 RESEARCH DESIGN 40 FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 42 FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024 43 FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024 44 FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER: REVENUE SHARE ANALYSIS, 2024 44 FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS 45 FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 46 FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2025–2030 47 FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS 48 FIGURE 11 DATA TRIANGULATION METHODOLOGY 49 FIGURE 12 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 52 FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 53 FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 53 FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54 FIGURE 16 LIVE CELL IMAGING MARKET: GEOGRAPHICAL SNAPSHOT 55 FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET 56 FIGURE 18 INSTRUMENTS SEGMENT AND US DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2024 57 FIGURE 19 INSTRUMENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 58 FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 58 FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN LIVE CELL IMAGING MARKET FROM 2025 TO 2030 59 FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 23 GLOBAL CANCER INCIDENCE AND MORTALITY, 2022 63 FIGURE 24 REVENUE SHIFT FOR PLAYERS IN LIVE CELL IMAGING MARKET 68 FIGURE 25 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS, BY KEY PLAYER, 2022–2024 71 FIGURE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 72 FIGURE 27 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 73 FIGURE 28 LIVE CELL IMAGING MARKET: ECOSYSTEM ANALYSIS 74 FIGURE 29 PATENT ANALYSIS OF LIVE CELL IMAGING MARKET, JANUARY 2014–APRIL 2025 81 FIGURE 30 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 92 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 94 FIGURE 32 KEY BUYING CRITERIA, BY END USER 95 FIGURE 33 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 202 FIGURE 34 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT 234 FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 293 FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 294 FIGURE 37 EV/EBITDA OF KEY PLAYERS, 2025 297 FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS, 2025 297 FIGURE 39 LIVE CELL IMAGING MARKET: BRAND/PRODUCT COMPARISON 298 FIGURE 40 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 300 FIGURE 41 LIVE CELL IMAGING MARKET: COMPANY FOOTPRINT 301 FIGURE 42 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 307 FIGURE 43 DANAHER: COMPANY SNAPSHOT (2024) 314 FIGURE 44 ZEISS GROUP: COMPANY SNAPSHOT (2024) 319 FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 324 FIGURE 46 REVVITY: COMPANY SNAPSHOT (2024) 328 FIGURE 47 SARTORIUS AG: COMPANY SNAPSHOT (2024) 332 FIGURE 48 NIKON CORPORATION: COMPANY SNAPSHOT (2023) 335 FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 340 FIGURE 50 BRUKER: COMPANY SNAPSHOT (2024) 345 FIGURE 51 BD: COMPANY SNAPSHOT (2024) 348 FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2024) 350 FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 353 FIGURE 54 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 355 FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 357 FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 359

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療與生命科學）